Revolution Medicines, Inc. vs Eli Lilly & Co.
RVMD vs LLY — side-by-side comparison from reported financials. RVMD leads 2, LLY leads 4 of 6 comparable metrics.
Revolution Medicines, Inc.
RVMD · Healthcare
$189.76+0.87%Mixed
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | RVMD | LLY |
|---|---|---|
| Price | $189.76 | $1 177.20 |
| Market cap | $40.7B | $1.05T |
| Revenue (TTM) | $0 | $79.7B |
| Revenue growth | — | +31.7% |
| Net margin | — | 33.5% |
| Free cash flow | -$2.65B | $18.2B |
| Net cash (debt) | $2.75B | ($35.2B) |
| 1-year price return | +298.5% | +37.6% |
| P/E | — | 41.6 |
| P/E vs own history (cheap-side %) | — | 88% |
| Dividend yield | — | 0.52% |
| Return on equity | -54% | 93% |
| Altman Z-score | — | 7.10 |
| CV checks passed | 3 of 8 | 11 of 8 |
| Employees | 883 | 50,000 |
Full résumé-style profiles: RVMD CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.